InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the complete record of transactions filed by Thackray Helen M., Directeur R&D. Director active across 1 company, notably Biocryst Pharmaceuticals INC. In total, 3 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €111k. Activity tracked since 14 December 2021. The latest transaction was disclosed on 1 April 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
7,600 shares@ US$16.200.0067% mcap100.0% of flowCommon StockSEC:0001127602-22-011188:0
44,000 shares0Common StockSEC:0001127602-21-031130
44,000 shares0Common StockSEC:0001127602-21-031130:0
3 of 3 declarations
About Thackray Helen M.
Helen M. Thackray is the Chief R&D Officer at BIOCRYST PHARMACEUTICALS INC. In this role, she oversees the company's research and development initiatives, focusing on innovation and product improvement. Helen brings scientific and technical expertise, enabling her to lead complex research projects. Her commitment to innovation is essential for the success of BIOCRYST.
